Safa Tahmasebi (S Tahmasebi)

ORCID

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 22

Top Venues

GeroScience

Medical oncology (Northwood, London, England)

Cancer cell international

Regenerative medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Mehran Izadi, Nariman Sadri, Amirhossein Abdi, Mohammad Mahdi Raeis Zadeh, Dorsa Jalaei, Mohammad Mahdi Ghazimoradi, Sara Shouri, Safa Tahmasebi
Longevity and anti-aging effects of curcumin supplementation. GeroScience 46 (3) (2024)
Mehran Izadi, Nariman Sadri, Amirhossein Abdi, Mohammad Mahdi Raeis Zadeh, Dorsa Jalaei, Mohammad Mahdi Ghazimoradi, Sara Shouri, Safa Tahmasebi
Longevity and anti-aging effects of curcumin supplementation. GeroScience 46 (3) (2024)
Mehran Izadi, Nariman Sadri, Amirhossein Abdi, Mohammad Mahdi Raeis Zadeh, Dorsa Jalaei, Mohammad Mahdi Ghazimoradi, Sara Shouri, Safa Tahmasebi
Longevity and anti-aging effects of curcumin supplementation. GeroScience 46 (3) (2024)
Mehran Izadi, Nariman Sadri, Amirhossein Abdi, Mohammad Mahdi Raeis Zadeh, Dorsa Jalaei, Mohammad Mahdi Ghazimoradi, Sara Shouri, Safa Tahmasebi
Longevity and anti-aging effects of curcumin supplementation. GeroScience (2024)
Mehran Izadi, Nariman Sadri, Amirhossein Abdi, Mohammad Mahdi Raeis Zadeh, Dorsa Jalaei, Mohammad Mahdi Ghazimoradi, Sara Shouri, Safa Tahmasebi
Longevity and anti-aging effects of curcumin supplementation. GeroScience 46 (3) (2024)
Mehran Izadi, Nariman Sadri, Amirhossein Abdi, Mohammad Mahdi Raeis Zadeh, Dorsa Jalaei, Mohammad Mahdi Ghazimoradi, Sara Shouri, Safa Tahmasebi
Longevity and anti-aging effects of curcumin supplementation. GeroScience 46 (3) (2024)
Mehran Izadi, Nariman Sadri, Amirhossein Abdi, Mohammad Mahdi Raeis Zadeh, Dorsa Jalaei, Mohammad Mahdi Ghazimoradi, Sara Shouri, Safa Tahmasebi
Longevity and anti-aging effects of curcumin supplementation. GeroScience 46 (3) (2024)
Mehran Izadi, Nariman Sadri, Amirhossein Abdi, Mohammad Mahdi Raeis Zadeh, Dorsa Jalaei, Mohammad Mahdi Ghazimoradi, Sara Shouri, Safa Tahmasebi
Longevity and anti-aging effects of curcumin supplementation. GeroScience 46 (3) (2024)
Maysoon Al-Haideri, Talar Ahmad Merza Mohammad, Shahram Darvishzadehdeldari, Zahra Karbasi, Mina Alimohammadi, Fatemeh Faramarzi, Sahar Khorasani, Ashkan Rasouli, Safa Tahmasebi, Talar Ahmad Merza Mohammad, Reza Akhavan-Sigari
Immunogenicity of COVID-19 vaccines in adult patients with autoimmune inflammatory rheumatic diseases: A systematic review and meta-analysis. International journal of rheumatic diseases (2023)
Mohammed Hikmat Faeq, Maysoon Al-Haideri, Talar Ahmad Merza Mohammad, Farshad Gharebakhshi, Faroogh Marofi, Safa Tahmasebi, Shadan Modaresahmadi
CAR-modified immune cells as a rapidly evolving approach in the context of cancer immunotherapies. Medical oncology (Northwood, London, England) 40 (5) (2023)
Kaveh Hadiloo, Safa Tahmasebi, Abdolreza Esmaeilzadeh
CAR-NKT cell therapy: a new promising paradigm of cancer immunotherapy. Cancer cell international 23 (1) (2023)
Mohammed Hikmat Faeq, Maysoon Al-Haideri, Talar Ahmad Merza Mohammad, Farshad Gharebakhshi, Faroogh Marofi, Safa Tahmasebi, Shadan Modaresahmadi
CAR-modified immune cells as a rapidly evolving approach in the context of cancer immunotherapies. Medical oncology (Northwood, London, England) 40 (5) (2023)
Kaveh Hadiloo, Safa Tahmasebi, Abdolreza Esmaeilzadeh
CAR-NKT cell therapy: a new promising paradigm of cancer immunotherapy. Cancer cell international 23 (1) (2023)
Mohammed Hikmat Faeq, Maysoon Al-Haideri, Talar Ahmad Merza Mohammad, Farshad Gharebakhshi, Faroogh Marofi, Safa Tahmasebi, Shadan Modaresahmadi
CAR-modified immune cells as a rapidly evolving approach in the context of cancer immunotherapies. Medical oncology (Northwood, London, England) 40 (5) (2023)
Mahmood Araghi, Reza Mannani, Ali Heidarnejad Maleki, Adel Hamidi, Samaneh Rostami, Salar Hozhabri Safa, Fatemeh Faramarzi, Sahar Khorasani, Mina Alimohammadi, Safa Tahmasebi, Reza Akhavan-Sigari
Recent advances in non-small cell lung cancer targeted therapy; an update review. Cancer cell international 23 (1) (2023)
Mohammed Hikmat Faeq, Maysoon Al-Haideri, Talar Ahmad Merza Mohammad, Farshad Gharebakhshi, Faroogh Marofi, Safa Tahmasebi, Shadan Modaresahmadi
CAR-modified immune cells as a rapidly evolving approach in the context of cancer immunotherapies. Medical oncology (Northwood, London, England) 40 (5) (2023)
Mohammed Hikmat Faeq, Maysoon Al-Haideri, Talar Ahmad Merza Mohammad, Farshad Gharebakhshi, Faroogh Marofi, Safa Tahmasebi, Shadan Modaresahmadi
CAR-modified immune cells as a rapidly evolving approach in the context of cancer immunotherapies. Medical oncology (Northwood, London, England) 40 (5) (2023)
Mohammed Hikmat Faeq, Maysoon Al-Haideri, Talar Ahmad Merza Mohammad, Farshad Gharebakhshi, Faroogh Marofi, Safa Tahmasebi, Shadan Modaresahmadi
CAR-modified immune cells as a rapidly evolving approach in the context of cancer immunotherapies. Medical oncology (Northwood, London, England) 40 (5) (2023)
Mohammed Hikmat Faeq, Maysoon Al-Haideri, Talar Ahmad Merza Mohammad, Farshad Gharebakhshi, Faroogh Marofi, Safa Tahmasebi, Shadan Modaresahmadi
CAR-modified immune cells as a rapidly evolving approach in the context of cancer immunotherapies. Medical oncology (Northwood, London, England) 40 (5) (2023)
Pegah Moharrami Yeganeh, Safa Tahmasebi, Abdolreza Esmaeilzadeh
Cellular and biological factors involved in healing wounds and burns and treatment options in tissue engineering. Regenerative medicine 17 (6) (2022)
Abdolreza Esmaeilzadeh, Samaneh Rostami, Pegah M Yeganeh, Safa Tahmasebi, Majid Ahmadi
Recent advances in antibody-based immunotherapy strategies for COVID-19. Journal of cellular biochemistry 122 (10) (2021)
Davood Jafari, Mohammad Javad Mousavi, Sanaz Keshavarz Shahbaz, L Jafarzadeh, Safa Tahmasebi, J Spoor, Abdolreza Esmaeilzadeh
E3 ubiquitin ligase Casitas B lineage lymphoma-b and its potential therapeutic implications for immunotherapy. Clinical and experimental immunology 204 (1) (2021)

Safa Tahmasebi.css-eqlu8i{font-size:small;padding-left:4px;} (S Tahmasebi)

Publication Activity (10 Years)

Top Topics

Top Venues

Safa Tahmasebi (S Tahmasebi)